{
    "code": "52027416",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027416",
    "time": "2019-01-25 03:35:23",
    "許可證字號": "衛部藥輸字第027416號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/04\/16",
    "發證日期": "107\/04\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202741602",
    "中文品名": "止黴捷凍晶注射液200毫克",
    "英文品名": "Alvoazole 200mg Lyophilized Powder for Solution for Infusion",
    "適應症": "一、治療侵犯性麴菌病（INVASIVE ASPERGILLOSIS）﹔二、治療嚴重之侵犯性念珠菌感染（SERIOUS INVASIVE CANDIDA INFECTIONS）﹔三、治療足分枝菌（SCEDOSPORIUM SPP.）和鐮刀菌（FUSARIUM SPP.）之嚴重黴菌感染﹔四、預防高危險患者發生侵入性黴菌感染，包括接受造血幹細胞移植（HSCT）的患者。",
    "劑型": "243凍晶注射劑",
    "包裝": "200毫克玻璃小瓶裝 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "VORICONAZOLE"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F160002400  ANFARM HELLAS S.A.",
        "製造廠廠址": "61ST KM NAT. RD. ATHENS-LAMIA, SCHIMATARI VIOTIAS, 32009, GREECE",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812204300",
            "成分名稱": "VORICONAZOLE",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Annex 05. purpose PIL-107-11-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027416&Seq=002&Type=9"
        },
        {
            "title": "Annex 06. Label-ArtworkProof_CompID_14575_Round_1-107-11-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027416&Seq=003&Type=8"
        },
        {
            "title": "Annex 06. Carton-ArtworkProof_CompID_14574_Round_1-107-11-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027416&Seq=002&Type=8"
        }
    ]
}